Literature DB >> 3024744

The Na+/H+ antiport of eukaryotic cells: relationship between the kinetic properties of the system and its physiological function.

C Frelin, P Barbry, R D Green, T Jean, P Vigne, M Lazdunski.   

Abstract

The Na+/H+ antiport is present in the plasma membrane of virtually all vertebrate cells and it plays a central role in cell homeostasis. The pharmacological properties and the characteristics of the interaction of extracellular Na+, Li+, H+ and of intracellular H+ with the Na+/H+ antiport are reviewed herein. The kinetic properties of the system are shown to be essential for defining its four main physiological functions: transepithelial ion transport, control of the pHi, control of the intracellular Na+ concentration, and control of the cell volume. The activity of the Na+/H+ antiport can be modulated by a large number of effectors which are thought to act via protein kinases. At least three mechanisms of activation of the Na+/H+ exchanger are defined from the analysis of the kinetic properties of the system. Activation of the Na+/H+ antiport leads to very different consequences, depending upon the activity of other ion transporting systems in the membrane.

Mesh:

Substances:

Year:  1986        PMID: 3024744     DOI: 10.1016/s0300-9084(86)80079-7

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  3 in total

1.  Cytoplasmic acidification and activation of Na+/H+ exchange during regulatory volume decrease in Ehrlich ascites tumor cells.

Authors:  A Livne; E K Hoffmann
Journal:  J Membr Biol       Date:  1990-03       Impact factor: 1.843

2.  Na+/H+ exchange in Ehrlich ascites tumor cells: activation by cytoplasmic acidification and by treatment with cupric sulphate.

Authors:  B Kramhøft; I H Lambert; E K Hoffmann
Journal:  J Membr Biol       Date:  1988-04       Impact factor: 1.843

3.  Sodium-hydrogen exchange in erythrocytes of patients with acute deep venous thromboses.

Authors:  S A Polykarpov; S N Orlov
Journal:  Experientia       Date:  1992-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.